Stock Price
0.07
Daily Change
-0.004 -5.11%
Monthly
12.72%
Yearly
-63.27%
Q1 Forecast
0.07

Bio Path reported $746K in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
Alterity Therapeutics Limited AUD 27.32M 6.07M Jun/2023
Baxter International USD 20.06B 1.01B Dec/2025
Bio Path USD 746K 1.45M Jun/2025
Cipla INR 401.64B 27.77B Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 97.84M 8.68M Sep/2025
CSL USD 37.9B 1.5B Dec/2025
Grifols EUR 23.29B 3.35M Sep/2025
Karyopharm Therapeutics USD 96.23M 8.65M Sep/2025